| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.003 | 27.593 | 24.518 | 22.824 | 1.422 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 27.003 | 27.593 | 24.518 | 22.824 | 1.422 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 8.060 | 11.562 | 8.828 | 9.004 | 2.294 | 0 | 0 | 30 | 30 | 30 |
| Gross Profit/Loss - EUR | 18.943 | 16.031 | 15.690 | 13.819 | -871 | 0 | 0 | -30 | -30 | -30 |
| Net Profit/Loss - EUR | 18.133 | 15.479 | 15.444 | 13.591 | -914 | 0 | 0 | -30 | -30 | -30 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Luxfarcas S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 45.492 | 43.692 | 57.923 | 70.307 | 67.470 | 66.191 | 43.652 | 43.757 | 43.594 | 43.320 |
| Inventories | 239 | 177 | 883 | 868 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 45.254 | 43.516 | 57.041 | 69.438 | 67.470 | 66.191 | 43.652 | 43.757 | 43.594 | 43.320 |
| Shareholders Funds | 44.249 | 19.257 | 34.376 | 47.336 | 45.505 | 44.642 | 43.652 | 43.757 | 43.594 | 43.320 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.243 | 24.435 | 23.548 | 22.971 | 21.965 | 21.549 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7729 - 7729" | |||||||||
| CAEN Financial Year |
7729
|
|||||||||
Comments - Luxfarcas S.r.l.